What impact will the new Urban Wastewater Treatment Directive really have on the pharma and cosmetic industries?
Webinar | 12.05.24, 2:00 PM CET - 3:15 PM CET
Address
Virtual December 5, 2024
What impact will the new Urban Wastewater Treatment Directive really have on the pharma and cosmetic industries?
Join us for an in-depth discussion led by industry experts and legal professionals as they demystify the complexities of the new Urban Wastewater Treatment Directive (UWWTD) and its impact on the pharmaceutical and cosmetic industries. This comprehensive webinar will cover:
- The background and context of the New UWWTD
- Impact assessments, scientific data and technical information regarding its adoption
- The directive’s scope and core requirements
- Likely impact on pharmaceutical and cosmetic products and supply chains
- Concerns of a chilling effect on growth and competitiveness
- Links to other EU and EEA law and policy aspects, including other EPR schemes
- The Swiss experience: different approaches and different funding models
Discover key insights through this in-depth discussion led by industry experts and legal professionals on the new UWWTD.
Speakers
- Marcus Navin-Jones, Senior Counsel, Crowell & Moring Brussels
- Ilona Kirhensteine, Associate Director - WSP
- Bryan Regan, PSCI - Associate Director Environmental Governance - Novartis
- Athina Giannoutsou, Associate Director of Public Affairs, EFPIA and The Inter-Association Task Force on Pharmaceuticals in the Environment (PiE)
- Carmela Ciarliero, Public Affairs Manager, Cosmetics Europe
Participants
- Luca Prosdocimo, Senior Manager International Trade and Public Affairs, Medicines for Europe
- Luis Rhodes Baiao PharmD, Governmental and Public Affairs Manager, AESGP
To learn more about this topic please read this article.
For more information, please visit these areas: Regulatory — Brussels Practice, Brussels Practice, Life Sciences — Brussels Practice, Environmental, Social, and Governance, Environment and Natural Resources, Sustainability and Environmental, Social, and Governance (ESG)
Participants
Insights
Webinar | 03.12.26
The federal government has identified purported ‘waste, fraud, and abuse’ in small business programs as a major focus of its current enforcement efforts. As it relates to federal procurement, we have seen audits and investigations rolled out not only of active participants in the Small Business Administration’s 8(a) Business Development Program but also reviews of various types of small business contracts (such as 8(a) sole source and set-aside awards, preference-based awards, and small business set-aside awards over particular values). Join Crowell & Moring as we discuss what aspects of contract performance and teaming arrangements are being scrutinized (e.g., size/status eligibility, limitations on subcontracting compliance, reasonableness of market rates, etc.) and how these considerations can impact both small government contractors holding the prime contracts under review and their subcontractors.
Webinar | 03.02.26
